Identification by differential tissue proteome analysis of Talin-1 as a novel molecular marker of progression of hepatocellular carcinoma

Oncology

Volumn 80, Issue 5-6, 2011, Pages 406-415

  Kanamori, Hideaki ^a   Kawakami, Takao ^b,c   Effendi, Kathryn ^a   Yamazaki, Ken ^a   Mori, Taisuke ^a   Ebinuma, Hirotoshi ^a   Masugi, Yohei ^a   Du, Wenlin ^a   Nagasaka, Keiko ^c   Ogiwara, Atsushi ^c   Kyono, Yutaka ^c   Tanabe, Minoru ^a   Saito, Hidetsugu ^a   Hibi, Toshifumi ^a   Sakamoto, Michiie ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c Medical ProteoScope Co Ltd   (Japan)

Author keywords

Disease free survival; Immunohistochemistry; Liquid chromatography tandem mass spectrometry; Portal vein invasion; Tumor progression

Indexed keywords

TALIN; TALIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CASE REPORT; CELL DEDIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; MALE; NUCLEOTIDE SEQUENCE; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY;

AGED; AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; PROTEOME; PROTEOMICS; TALIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80051588566     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000330734     Document Type: Article

References (26)

1. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, Kosuge T, Motoo Y, Yamazaki S, Hasegawa H: Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990; 336: 1150-1153. (Pubitemid 20362906)
2. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, Kosuge T, Okada S, Takayasu K, Yamasaki S: Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: 1241-1246. (Pubitemid 28493833)
3. International Consensus Group for Hepatocellular Neoplasia: Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia. Hepatology 2009; 49: 658-664.
4. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, Hirohashi S: Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003; 37: 198-207. (Pubitemid 36042161)
5. Shibata R, Mori T, Du W, Chuma M, Gotoh M, Shimazu M, Ueda M, Hirohashi S, Sakamoto M: Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin Cancer Res 2006; 12: 5363-5368. (Pubitemid 44497249)
6. McDonald WH, Yates JR 3rd: Shotgun proteomics: Integrating technologies to answer biological questions. Curr Opin Mol Ther 2003; 5: 302-309. (Pubitemid 37185350)
7. Critchley DR: Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. Biochem Soc Trans 2004; 32: 831-836. (Pubitemid 39524391)
8. Maeda J, Hirano T, Ogiwara A, Akimoto S, Kawakami T, Fukui Y, Oka T, Gong Y, Guo R, Inada H, Nawa K, Kojika M, Suga Y, Ohira T, Mukai K, Kato H: Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy. Br J Cancer 2008; 98: 596-603. (Pubitemid 351214526)
9. Hibi T, Mori T, Fukuma M, Yamazaki K, Hashiguchi A, Yamada T, Tanabe M, Aiura K, Kawakami T, Ogiwara A, Kosuge T, Kitajima M, Kitagawa Y, Sakamoto M: Synuclein- gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 2864-2871.
10. Fujii K, Nakano T, Kanazawa M, Akimoto S, Hirano T, Kato H, Nishimura T: Clinicalscale high-throughput human plasma proteome analysis: Lung adenocarcinoma. Proteomics 2005; 5: 1150-1159. (Pubitemid 40469042)
11. Marko-Varga G, Ogiwara A, Nishimura T, et al: Personalized medicine and proteomics: Lessons from non-small cell lung cancer. J Proteome Res 2007; 6: 2925-2935. (Pubitemid 47315558)
12. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20: 3551-3567. (Pubitemid 30007252)
13. Hsu SM, Raine L, Fanger H: Use of avidinbiotin- peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580. (Pubitemid 11147380)
14. Chuma M, Saeki N, Yamamoto Y, Ohta T, Asaka M, Hirohashi S, Sakamoto M: Expression profiling in hepatocellular carcinoma with intrahepatic metastasis: Identification of high-mobility group I(Y) protein as a molecular marker of hepatocellular carcinoma metastasis. Keio J Med 2004; 53: 90-97. (Pubitemid 38899742)
15. Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev 2009; 28: 5-14.
16. Yamazaki K, Takamura M, Masugi Y, Mori T, Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S, Sakamoto M: Adenylate cyclase- associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Lab Invest 2009; 89: 425-432.
17. Ai J, Huang H, Lv X, Tang Z, Chen M, Chen T, Duan W, Sun H, Li Q, Tan R, Liu Y, Duan J, Yang Y, Wei Y, Li Y, Zhou Q: FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem 2011; 27: 207-216.
18. Calderwood DA: Integrin activation. J Cell Sci 2004; 117: 657-666. (Pubitemid 38268081)
19. Franco SJ, Rodgers MA, Perrin BJ, Han J, Bennin DA, Critchley DR, Huttenlocher A: Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 2004; 6: 977-983. (Pubitemid 39359850)
20. Hu K, Ji L, Applegate KT, Danuser G, Waterman- Storer CM: Differential transmission of actin motion within focal adhesions. Science 2007; 315: 111-115. (Pubitemid 46196992)
21. Sakamoto S, McCann RO, Dhir R, Kyprianou N: Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 2010; 70: 1885-95.
22. Chen HC, Appeddu PA, Parsons JT, Hildebrand JD, Schaller MD, Guan JL: Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 1995; 270: 16995-16999.
23. Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W, Bi J: FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 2010; 27: 71-82.
24. Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008; 48: 1312-1327.
25. Hanash SM, Pitteri SJ, Faca VM: Mining the plasma proteome for cancer biomarkers. Nature 2008; 452: 571-579. (Pubitemid 351483371)
26. America AH, Cordewener JH: Comparative LC-MS: A landscape of peaks and valleys. Proteomics 2008; 8: 731-749. (Pubitemid 351362933)